← Browse by Condition
Medical Condition

autism spectrum disorder asd

Total Trials
8
Recruiting Now
8
Trial Phases
Phase 1, Phase 2, Phase 2

Autism spectrum disorder (ASD) trials target core symptoms (social communication, restricted/repetitive behaviors) as well as co-occurring conditions including anxiety, sleep disturbance, and gastrointestinal problems. The heterogeneity of ASD β€” driven by hundreds of genetic variants β€” has driven interest in genotype-stratified trials that enroll specific genetic subtypes (SHANK3, CHD8, FMR1).

Trials evaluate oxytocin nasal spray, vasopressin receptor modulators, mGluR5 antagonists in fragile X, bumetanide (GABA modulator), transcranial magnetic stimulation, and early intensive behavioral interventions. Biomarkers including EEG connectivity measures and eye-tracking are being validated as objective outcome measures.

Frequently Asked Questions — autism spectrum disorder asd Clinical Trials

How many clinical trials are currently recruiting for autism spectrum disorder asd?
ClinicalMetric currently tracks 8 actively recruiting clinical trials for autism spectrum disorder asd, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 8. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for autism spectrum disorder asd?
autism spectrum disorder asd research spans Phase 1 (1 trial), Phase 2 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a autism spectrum disorder asd clinical trial?
Eligibility criteria for autism spectrum disorder asd trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1
1
Phase 2
2
Top Sponsors
Centre Hospitalier Intercommunal Robert Ballanger 1 trial
Healing Hope International 1 trial
University of California, Los Angeles 1 trial
The University of Texas Health Science Center, Houston 1 trial
Dongfang People's Hospital 1 trial

Recruiting Clinical Trials

NCT06443320
Recruiting
Evaluation of the Videodrama Therapeutic Device for Children With Autism Spectrum Disorders
Enrollment
30 pts
Location
France
Sponsor
Centre Hospitalier Intercommun...
View Trial →
NCT07493096
Recruiting
Intensive Multimodal Neurorehabilitation Targeting Neuroplasticity in Pediatric Neurodevelopmental and Chromosomal Disorders
Enrollment
100 pts
Location
United States
Sponsor
Healing Hope International
View Trial →
NCT07276750
Recruiting
Coaching and Leadership in Autism Support Settings
Enrollment
373 pts
Location
United States
Sponsor
University of California, Los ...
View Trial →
NCT06868537
Recruiting
A Trial of the Launching! to Adulthood Program
Enrollment
40 pts
Location
United States
Sponsor
The University of Texas Health...
View Trial →
NCT07243561 Phase 1, Phase 2
Recruiting
Prospective Clinical Study on Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes for the Treatment of Childhood Autism
Enrollment
60 pts
Location
China
Sponsor
Dongfang People's Hospital
View Trial →
NCT07495761
Recruiting
Prospective Study to Determine the Prevalence of Signs of Central Sensitization in Adults With ASD Without Intellectual Developmental Disorders
Enrollment
100 pts
Location
France
Sponsor
Groupe Hospitalier Mutualiste ...
View Trial →
NCT06829303
Recruiting
BCI Training for Social Cognition and Error Monitoring in ASD
Enrollment
28 pts
Location
Portugal
Sponsor
University of Coimbra
View Trial →
NCT06951854 Phase 2
Recruiting
Phase II Clinical Trial to Evaluate the Efficacy and Safety of NV01-A02 in Children With Autism Spectrum Disorder
Enrollment
105 pts
Location
South Korea
Sponsor
Neuroventi Inc.
View Trial →

Related Conditions

neurodevelopmental disorders (1) neurodevelopmental disorders ndd (1) neurodevelopmental disorders and developmental abnormalities (1) developmental delay disorder (1) cerebral palsy cp (1) cerebral palsy hemiparetic cerebral palsy spasticity gait disorders neurologic postural balance impairment (1) cerebral palsy infantile (1) cerebral palsy spastic hemiplegic (1) cerebral palsy dyskinetic (1) autism spectrum disorder (1) hypoxic ischemic encephalopathy (1) hypoxic ischemic encephalopathy hie (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology